- Home
- AGIO vs BANR Comparison
AGIO vs BANR Comparison
Compare AGIO & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- BANR
- Stock Information
- Founded
- AGIO 2007
- BANR 1890
- Country
- AGIO United States
- BANR United States
- Employees
- AGIO N/A
- BANR N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- BANR Major Banks
- Sector
- AGIO Health Care
- BANR Finance
- Exchange
- AGIO Nasdaq
- BANR Nasdaq
- Market Cap
- AGIO 2.0B
- BANR 2.3B
- IPO Year
- AGIO 2013
- BANR 1995
- Fundamental
- Price
- AGIO $35.22
- BANR $67.28
- Analyst Decision
- AGIO Buy
- BANR Buy
- Analyst Count
- AGIO 7
- BANR 6
- Target Price
- AGIO $56.33
- BANR $73.80
- AVG Volume (30 Days)
- AGIO 621.1K
- BANR 178.8K
- Earning Date
- AGIO 02-13-2025
- BANR 04-16-2025
- Dividend Yield
- AGIO N/A
- BANR 2.81%
- EPS Growth
- AGIO N/A
- BANR N/A
- EPS
- AGIO 11.64
- BANR 4.88
- Revenue
- AGIO $36,498,000.00
- BANR $601,023,000.00
- Revenue This Year
- AGIO $166.22
- BANR N/A
- Revenue Next Year
- AGIO $98.36
- BANR $6.35
- P/E Ratio
- AGIO $3.03
- BANR $13.99
- Revenue Growth
- AGIO 36.07
- BANR N/A
- 52 Week Low
- AGIO $27.14
- BANR $42.00
- 52 Week High
- AGIO $62.58
- BANR $78.05
- Technical
- Relative Strength Index (RSI)
- AGIO 54.02
- BANR 41.02
- Support Level
- AGIO $33.25
- BANR $67.81
- Resistance Level
- AGIO $34.86
- BANR $70.06
- Average True Range (ATR)
- AGIO 1.33
- BANR 1.62
- MACD
- AGIO 0.37
- BANR -0.29
- Stochastic Oscillator
- AGIO 97.99
- BANR 4.08
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.